$NRX NephroGenex, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NephroGenex, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NephroGenex, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in NephroGenex, Inc. for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NRX
Company Address: P.O. BOX 400 JAMISON 18929
Phone number: (609) 986-1780
Former name: NephroGenex Inc, date of change: 2005-09-07
Prev close: $0.14
Average Daily Volume: 288,621
Days Low: $0.00
Year Low: $0.10
Year High: $8.90
NephroGenex, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10 2015 | NRX | NephroGenex, Inc. | Steiner Eugen | Director | Grant | A | 0.00 | 76,045 | 0 | 76,045 | 0 to 76 K |
| Nov 12 2015 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Grant | A | 0.00 | 646,930 | 0 | 659,430 | 12.5 K to 659.4 K (+5,175.44 %) |
| Nov 12 2015 | NRX | NephroGenex, Inc. | Hamill John | Chief Financial Off ... | Grant | A | 0.00 | 136,381 | 0 | 136,381 | 0 to 136.4 K |
| Nov 12 2015 | NRX | NephroGenex, Inc. | Patel Jaikrishna | Chief Medical Offic ... | Grant | A | 0.00 | 97,306 | 0 | 97,306 | 0 to 97.3 K |
| Aug 07 2015 | NRX | NephroGenex, Inc. | Patel Jaikrishna | Chief Medical Offic ... | Option Exercise | A | 4.12 | 54,347 | 223,910 | 54,347 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Fox J. Wesley | Pres. & Chief Sci. ... | Option Exercise | A | 7.31 | 15,000 | 109,650 | 15,000 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Taglietti Marco | Director | Option Exercise | A | 7.31 | 6,870 | 50,220 | 6,870 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Steiner Eugen | Director | Option Exercise | A | 7.31 | 6,870 | 50,220 | 6,870 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Option Exercise | A | 7.31 | 6,870 | 50,220 | 6,870 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Peterson Bob | VP of Prod. Dev. & ... | Option Exercise | A | 7.31 | 11,500 | 84,065 | 11,500 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Mitchum James P. | Director | Option Exercise | A | 7.31 | 13,740 | 100,439 | 13,740 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Option Exercise | A | 7.31 | 6,870 | 50,220 | 6,870 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Option Exercise | A | 7.31 | 50,000 | 365,500 | 50,000 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Hamill John | Chief Financial Off ... | Option Exercise | A | 7.31 | 15,000 | 109,650 | 15,000 | |
| Jan 06 2015 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | 10% Owner | Sell | S | 9.90 | 20,941 | 207,339 | 1,052,966 | 1.1 M to 1.1 M (-1.95 %) |